Cargando…
Left Ventricular Diastolic Function Following Anthracycline-Based Chemotherapy in Patients with Breast Cancer without Previous Cardiac Disease—A Meta-Analysis
Background: Anthracycline-based chemotherapy (ANT) remains among the most effective therapies for breast cancer. Cardiotoxicity from ANT represents a severe adverse event and may predominantly manifest as heart failure. While it is well-recognised that left ventricular systolic heart failure assessm...
Autores principales: | Mincu, Raluca I., Lampe, Lena F., Mahabadi, Amir A., Kimmig, Rainer, Rassaf, Tienush, Totzeck, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432074/ https://www.ncbi.nlm.nih.gov/pubmed/34501337 http://dx.doi.org/10.3390/jcm10173890 |
Ejemplares similares
-
Novel anticoagulants versus vitamin K antagonists for cardioversion of non- valvular atrial fibrillation – a meta-analysis of more than 17000 patients
por: Mincu, Raluca Ileana, et al.
Publicado: (2019) -
Association of echocardiographic measures of left ventricular diastolic dysfunction and hypertrophy with presence of coronary microvascular dysfunction
por: Dykun, Iryna, et al.
Publicado: (2020) -
Cardiovascular Adverse Events in Patients With Cancer Treated With Bevacizumab: A Meta‐Analysis of More Than 20 000 Patients
por: Totzeck, Matthias, et al.
Publicado: (2017) -
Impact of left-ventricular end-diastolic pressure as a predictor of periprocedural hemodynamic deterioration in patients undergoing Impella supported high-risk percutaneous coronary interventions
por: Al-Rashid, Fadi, et al.
Publicado: (2019) -
Right ventricular and atrial strain in patients with advanced melanoma undergoing immune checkpoint inhibitor therapy
por: Pohl, Julia, et al.
Publicado: (2022)